Covestor’s MBX Biosciences MBX Stock Holding History

Covestor’s Portfolio MBX Stock Details MBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Buy	10 +7	+233%	+$244	﹤0.01%	2416
2026 Q1	$0	Buy	+3	New	+$102	﹤0.01%	2871

Other funds holding MBX

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Covestor's MBX Position: Q2 2026 in Review

Covestor increased its MBX Biosciences (MBX) stake by 233% in Q2 2026, buying an estimated $244 and bringing the position to 10 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2416.

Covestor first reported a position in MBX in Q1 2026 and has held it in 2 quarters since. 173 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

Covestor held 10 shares of MBX Biosciences worth $1K as of Q2 2026.
Covestor bought 7 MBX Biosciences shares in Q2 2026, an estimated $244.
MBX Biosciences made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2416 holding.
Covestor first reported a position in MBX Biosciences in Q1 2026 and has held it in 2 quarters since.
173 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.